Ellis Investment Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.19M | Sell |
24,852
-250
| -1% | -$29.3K | 0.48% | 45 |
|
|
2026
Q1 | $3.02M | Sell |
25,102
-2,670
| -10% | -$308K | 0.52% | 39 |
|
|
2025
Q4 | $2.92M | Sell |
27,772
-1,399
| -5% | -$131K | 0.51% | 44 |
|
|
2025
Q3 | $2.45M | Buy |
29,171
+740
| +3% | +$61K | 0.44% | 50 |
|
|
2025
Q2 | $2.25M | Buy |
28,431
+173
| +0.6% | +$13.8K | 0.44% | 52 |
|
|
2025
Q1 | $2.54M | Buy |
28,258
+1,959
| +7% | +$183K | 0.52% | 43 |
|
|
2024
Q4 | $2.62M | Buy |
26,299
+792
| +3% | +$81.7K | 0.52% | 45 |
|
|
2024
Q3 | $2.9M | Buy |
25,507
+1,584
| +7% | +$188K | 0.56% | 44 |
|
|
2024
Q2 | $2.96M | Sell |
23,923
-140
| -0.6% | -$18K | 0.63% | 36 |
|
|
2024
Q1 | $3.18M | Buy |
24,063
+46
| +0.2% | +$5.67K | 0.69% | 34 |
|
|
2023
Q4 | $2.62M | Sell |
24,017
-13
| -0.1% | -$1.35K | 0.61% | 41 |
|
|
2023
Q3 | $2.47M | Sell |
24,030
-80
| -0.3% | -$8.62K | 0.64% | 41 |
|
|
2023
Q2 | $2.78M | Buy |
24,110
+598
| +3% | +$67.9K | 0.68% | 36 |
|
|
2023
Q1 | $2.5M | Sell |
23,512
-316
| -1% | -$34.1K | 0.65% | 39 |
|
|
2022
Q4 | $2.64M | Sell |
23,828
-319
| -1% | -$32.6K | 0.72% | 37 |
|
|
2022
Q3 | $2.08M | Buy |
24,147
+73
| +0.3% | +$6.52K | 0.58% | 43 |
|
|
2022
Q2 | $2.19M | Sell |
24,074
-308
| -1% | -$27.3K | 0.59% | 41 |
|
|
2022
Q1 | $2M | Sell |
24,382
-750
| -3% | -$59.1K | 0.47% | 47 |
|
|
2021
Q4 | $1.93M | Buy |
25,132
+1,374
| +6% | +$109K | 0.44% | 50 |
|
|
2021
Q3 | $1.78M | Buy |
23,758
+697
| +3% | +$53K | 0.45% | 48 |
|
|
2021
Q2 | $1.79M | Sell |
23,061
-971
| -4% | -$72.2K | 0.46% | 48 |
|
|
2021
Q1 | $1.77M | Sell |
24,032
-358
| -1% | -$26.4K | 0.49% | 44 |
|
|
2020
Q4 | $1.9M | Buy |
24,390
+975
| +4% | +$74.6K | 0.58% | 41 |
|
|
2020
Q3 | $1.85M | Buy |
23,415
+1,340
| +6% | +$105K | 0.65% | 34 |
|
|
2020
Q2 | $1.65M | Buy |
22,075
+462
| +2% | +$34.8K | 0.62% | 38 |
|
|
2020
Q1 | $1.52M | Buy |
21,613
+385
| +2% | +$30.3K | 0.72% | 30 |
|
|
2019
Q4 | $1.86M | Buy |
21,228
+122
| +0.6% | +$10K | 0.62% | 34 |
|
|
2019
Q3 | $1.68M | Buy |
21,106
+582
| +3% | +$46.6K | 0.61% | 34 |
|
|
2019
Q2 | $1.66M | Buy |
20,524
+412
| +2% | +$31.5K | 0.62% | 34 |
|
|
2019
Q1 | $1.6M | Sell |
20,112
-875
| -4% | -$65.4K | 0.65% | 37 |
|
|
2018
Q4 | $1.52M | Buy |
+20,987
| New | +$1.48M | 0.7% | 35 |
|
Other funds holding MRK
Ellis Investment Partners's MRK Position: Q2 2026 in Review
Ellis Investment Partners reduced its Merck (MRK) stake by 1% in Q2 2026, selling an estimated $29.3K and leaving 24,852 shares worth $3.19M. The position accounts for 0.48% of the portfolio, ranked #45.
Ellis Investment Partners first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Ellis Investment Partners held 24,852 shares of Merck worth $3.19M as of Q2 2026.
- Ellis Investment Partners sold 250 Merck shares in Q2 2026, an estimated $29.3K.
- Merck made up 0.48% of Ellis Investment Partners's portfolio in Q2 2026, its #45 holding.
- Ellis Investment Partners first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Ellis Investment Partners's 13F filing for Q2 2026, filed 5 Aug 2026.